D J Stein1, C S Kogan2, M Atmaca3, N A Fineberg4, L F Fontenelle5, J E Grant6, H Matsunaga7, Y C J Reddy8, H B Simpson9, P H Thomsen10, O A van den Heuvel11, D Veale12, D W Woods13, G M Reed14. 1. Department of Psychiatry and MRC Unit on Anxiety and Stress Disorders, University of Cape Town, Groote Schuur Hospital, Cape Town, South Africa. Electronic address: dan.stein@uct.ac.za. 2. School of Psychology, University of Ottawa, Ottawa, Canada. 3. Department of Psychiatry, School of Medicine, Firat (Euphrates) University, Elazig, Turkey. 4. Highly Specialized Obsessive Compulsive and Related Disorders Service, Hertfordshire Partnership University NHS Foundation Trust, Rosanne House, Welwyn Garden City, UK; Postgraduate Medical School, University of Hertfordshire, Hatfield, UK; University of Cambridge, School of Clinical Medicine, Cambridge, UK. 5. Institute of Psychiatry, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil; "D'Or' Institute for Research and Education, Rio de Janeiro, RJ, Brazil; School of Psychological Sciences, Monash University, Melbourne, Australia. 6. Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL, USA. 7. Department of Neuropsychiatry, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya Hyogo, Japan. 8. National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India. 9. College of Physicians and Surgeons, Columbia University Medical College, New York, NY, USA; Anxiety Disorders Clinic and the Center for OCD and Related Disorders, New York State Psychiatric Institute, New York, NY, USA. 10. Centre for Child and Adolescent Psychiatry, Aarhus University Hospital, Risskov, Aarhus, Denmark. 11. Department of Psychiatry, VU University Medical Center (VUmc), Amsterdam, The Netherlands; Department of Anatomy & Neurosciences, VUmc, Amsterdam, The Netherlands. 12. Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK; Center for Anxiety Disorders and Trauma, South London and Maudsley NHS Foundation Trust, London, UK. 13. Psychology Department, Texas A&M University, College Station, TX, USA. 14. Department of Psychology, National Autonomous University of Mexico (UNAM), Mexico, DF, Mexico; National Institute of Psychiatry "Ramón de la Fuente Muñiz", Mexico, DF, Mexico; Department of Mental Health and Substance Abuse, World Health Organization, Geneva, Switzerland.
Abstract
BACKGROUND: To present the rationale for the new Obsessive-Compulsive and Related Disorders (OCRD) grouping in the Mental and Behavioural Disorders chapter of the Eleventh Revision of the World Health Organization's International Classification of Diseases and Related Health Problems (ICD-11), including the conceptualization and essential features of disorders in this grouping. METHODS: Review of the recommendations of the ICD-11 Working Group on the Classification for OCRD. These sought to maximize clinical utility, global applicability, and scientific validity. RESULTS: The rationale for the grouping is based on common clinical features of included disorders including repetitive unwanted thoughts and associated behaviours, and is supported by emerging evidence from imaging, neurochemical, and genetic studies. The proposed grouping includes obsessive-compulsive disorder, body dysmorphic disorder, hypochondriasis, olfactory reference disorder, and hoarding disorder. Body-focused repetitive behaviour disorders, including trichotillomania and excoriation disorder are also included. Tourette disorder, a neurological disorder in ICD-11, and personality disorder with anankastic features, a personality disorder in ICD-11, are recommended for cross-referencing. LIMITATIONS: Alternative nosological conceptualizations have been described in the literature and have some merit and empirical basis. Further work is needed to determine whether the proposed ICD-11 OCRD grouping and diagnostic guidelines are mostly likely to achieve the goals of maximizing clinical utility and global applicability. CONCLUSION: It is anticipated that creation of an OCRD grouping will contribute to accurate identification and appropriate treatment of affected patients as well as research efforts aimed at improving our understanding of the prevalence, assessment, and management of its constituent disorders.
BACKGROUND: To present the rationale for the new Obsessive-Compulsive and Related Disorders (OCRD) grouping in the Mental and Behavioural Disorders chapter of the Eleventh Revision of the World Health Organization's International Classification of Diseases and Related Health Problems (ICD-11), including the conceptualization and essential features of disorders in this grouping. METHODS: Review of the recommendations of the ICD-11 Working Group on the Classification for OCRD. These sought to maximize clinical utility, global applicability, and scientific validity. RESULTS: The rationale for the grouping is based on common clinical features of included disorders including repetitive unwanted thoughts and associated behaviours, and is supported by emerging evidence from imaging, neurochemical, and genetic studies. The proposed grouping includes obsessive-compulsive disorder, body dysmorphic disorder, hypochondriasis, olfactory reference disorder, and hoarding disorder. Body-focused repetitive behaviour disorders, including trichotillomania and excoriation disorder are also included. Tourette disorder, a neurological disorder in ICD-11, and personality disorder with anankastic features, a personality disorder in ICD-11, are recommended for cross-referencing. LIMITATIONS: Alternative nosological conceptualizations have been described in the literature and have some merit and empirical basis. Further work is needed to determine whether the proposed ICD-11 OCRD grouping and diagnostic guidelines are mostly likely to achieve the goals of maximizing clinical utility and global applicability. CONCLUSION: It is anticipated that creation of an OCRD grouping will contribute to accurate identification and appropriate treatment of affected patients as well as research efforts aimed at improving our understanding of the prevalence, assessment, and management of its constituent disorders.
Authors: Geoffrey M Reed; Pratap Sharan; Tahilia J Rebello; Jared W Keeley; María Elena Medina-Mora; Oye Gureje; José Luis Ayuso-Mateos; Shigenobu Kanba; Brigitte Khoury; Cary S Kogan; Valery N Krasnov; Mario Maj; Jair de Jesus Mari; Dan J Stein; Min Zhao; Tsuyoshi Akiyama; Howard F Andrews; Elson Asevedo; Majda Cheour; Tecelli Domínguez-Martínez; Joseph El-Khoury; Andrea Fiorillo; Jean Grenier; Nitin Gupta; Lola Kola; Maya Kulygina; Itziar Leal-Leturia; Mario Luciano; Bulumko Lusu; J Nicolas; I Martínez-López; Chihiro Matsumoto; Lucky Umukoro Onofa; Sabrina Paterniti; Shivani Purnima; Rebeca Robles; Manoj K Sahu; Goodman Sibeko; Na Zhong; Michael B First; Wolfgang Gaebel; Anne M Lovell; Toshimasa Maruta; Michael C Roberts; Kathleen M Pike Journal: World Psychiatry Date: 2018-06 Impact factor: 49.548
Authors: Michael B First; Wolfgang Gaebel; Mario Maj; Dan J Stein; Cary S Kogan; John B Saunders; Vladimir B Poznyak; Oye Gureje; Roberto Lewis-Fernández; Andreas Maercker; Chris R Brewin; Marylene Cloitre; Angelica Claudino; Kathleen M Pike; Gillian Baird; David Skuse; Richard B Krueger; Peer Briken; Jeffrey D Burke; John E Lochman; Spencer C Evans; Douglas W Woods; Geoffrey M Reed Journal: World Psychiatry Date: 2021-02 Impact factor: 49.548
Authors: Ted Avi Gerstenblith; Ashley Jaramillo-Huff; Tuua Ruutiainen; Paul S Nestadt; Jack F Samuels; Marco A Grados; Bernadette A Cullen; Mark A Riddle; Kung-Yee Liang; Benjamin D Greenberg; Steven A Rasmussen; Scott L Rauch; James T McCracken; John Piacentini; James A Knowles; Gerald Nestadt; O Joseph Bienvenu Journal: Compr Psychiatry Date: 2019-08-31 Impact factor: 3.735
Authors: Dan J Stein; Daniel L C Costa; Christine Lochner; Euripedes C Miguel; Y C Janardhan Reddy; Roseli G Shavitt; Odile A van den Heuvel; H Blair Simpson Journal: Nat Rev Dis Primers Date: 2019-08-01 Impact factor: 52.329
Authors: Geoffrey M Reed; Michael B First; Cary S Kogan; Steven E Hyman; Oye Gureje; Wolfgang Gaebel; Mario Maj; Dan J Stein; Andreas Maercker; Peter Tyrer; Angelica Claudino; Elena Garralda; Luis Salvador-Carulla; Rajat Ray; John B Saunders; Tarun Dua; Vladimir Poznyak; María Elena Medina-Mora; Kathleen M Pike; José L Ayuso-Mateos; Shigenobu Kanba; Jared W Keeley; Brigitte Khoury; Valery N Krasnov; Maya Kulygina; Anne M Lovell; Jair de Jesus Mari; Toshimasa Maruta; Chihiro Matsumoto; Tahilia J Rebello; Michael C Roberts; Rebeca Robles; Pratap Sharan; Min Zhao; Assen Jablensky; Pichet Udomratn; Afarin Rahimi-Movaghar; Per-Anders Rydelius; Sabine Bährer-Kohler; Ann D Watts; Shekhar Saxena Journal: World Psychiatry Date: 2019-02 Impact factor: 49.548